Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

Sergio Siragusa, Mariasanta Napolitano, Elisabetta Cerchiara, Giorgia Saccullo, Augusto B. Federici, Monica Carpenedo, Laura Contino, Antonio Chistolini, Marco Marietta, Giancarlo Castaman, Valerio De Stefano, Anna Falanga, Augusto B. Federici, Rita Santoro, Elena Rossi

Risultato della ricerca: Articlepeer review

19 Citazioni (Scopus)

Abstract

Management of venous thromboembolism (VTE) in patients with haematologic malignancies and thrombocytopenia is clinically challenging due to the related risks. No prospective studies or clinical trials have been carried out and, therefore, no solid evidence on this compelling issue is available.
Lingua originaleEnglish
pagine (da-a)171-180
Numero di pagine10
RivistaBlood Transfusion
Volume17
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2723???
  • ???subjectarea.asjc.2700.2720???

Fingerprint

Entra nei temi di ricerca di 'Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus'. Insieme formano una fingerprint unica.

Cita questo